Increased demand for drugs used in hospitals as painkillers and surgical anesthetics for patients with COVID-19 have sapped supply, potentially threatening access for months.
The FDA posted updated shortages of anesthetics propofol and midazolam, citing increased demand. For generic propofol, produced by a number of manufacturers, a resupply could occur as late as October with companies like Dr. Reddy’s Laboratories and Hikma Pharmaceuticals unable to source active pharmaceutical ingredients for the drug, the FDA said.
For midazolam, meanwhile, certain doses are still available, according to the FDA, but other doses may not be until early 2021 at the latest.
The U.S. Drug Enforcement Agency (DEA) said last week it would allow increased production and imports of midazolam, a controlled substance, to combat ongoing shortages...
Full news text on GMPnews.Net
SOURCE: FIERCEPHARMA.COM